Gamma Medica files for bankruptcy

Gamma Medica-Ideas and its related entities have filed for Chapter 11 Bankruptcy protection on Aug. 20 in the U.S. Bankruptcy Court, Central District of California in Woodland Hills. 

All unsecured claims will be addressed during the bankruptcy process, the company said in an email to Health Imaging.

The court gave them until Sept. 4 to submit a list of equity security holders, as well as a declaration of debtors.

Northridge, Calif.-based Gamma Medica builds and services medical imaging systems based on technologies that will seek to bring systems into the digital era with its sensor readout systems. Its clinical imaging division's foremost product is the FDA-approved LumaGEM MBI (molecular breast imaging) system, which is planar, dual-head, solid-state digital imaging system utilizing cadmium zinc telluride technology used for breast imaging.



Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.